Group leader

Sergei Tillib
Ph.D., Dr.Sc.
Group Leader
Lab. of Molecular Biotechnologies

Research interests:

molecular immunology, single-domain antibody, phage display, epigenetic regulation of gene activity,

medical diagnostics, immunotherapy, vaccine development

Information

The main focus of investigations: the development of new molecular biotechnologies based on the production and the use of recombinant single-domain antibodies (sdAbs, nanobodies) for creating new materials and methods for research, diagnostics and therapy. Development of a method for the antigen tracing in vivo based on nanobody-fluorescent protein fusion probe that is expressing within a living cell or an organism.

Group members

Selected publications

Funding

foundation Title
RAS
RFBR  

Additional information